Taeguk Pharmaceutical's blemish care brand, DOMINAS, has recently surpassed 200 billion KRW in cumulative sales through home shopping channels, solidifying its reputation as a leading brand in South Korea.
DOMINAS, a derma cosmetic brand that encapsulates Taeguk Pharmaceutical's 69 years of R&D expertise, gained rapid popularity due to its effective formulations since its launch. Notably, it achieved the milestone of 200 billion KRW in cumulative sales on GS Home Shopping. Its bestseller, DOMINAS Cream, has held the number one position in the cream category by order sales on GS Home Shopping for five consecutive years since 2022, boasting a customer loyalty rate with a repurchase rate nearing 60%.
In response to customer support, DOMINAS recently launched the DOMINAS Cream 7X, enhancing the efficacy for the improvement of blemish area by more than threefold. This product incorporates the key brightening ingredient, tranexamic acid, in liposome form, which increases skin absorption by approximately 1.3 times compared to the previous generation 6X product.
DOMINAS continues to expand its product lineup to meet diverse customer needs. This includes the Hyper P-Toning Ampoule, known for its blemish treatment capabilities; the Bright Perfect Cover Cushion to address blemish correction and coverage simultaneously; as well as a comprehensive range that includes essences, sun care products, and mask packs.
A representative from Taeguk Pharmaceutical stated, "Thanks to our customers who trust our blemish care technology, the DOMINAS brand has seen significant growth. We intend to leverage this achievement to widely promote the remarkable efficacy of DOMINAS Cream and elevate it as a leading global K-Derma brand beyond South Korea."
